Johnson & Johnson Innovative Medicine at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

Johnson & Johnson Innovative Medicine brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on the process and handling questions behind advanced therapy supply. Topics include managing temperature excursions in practice and how shear stress destabilises self-amplifying RNA in lipid nanoparticles during process development.

OrganizationESGCT 2026 Attendance
Johnson & Johnson Innovative Medicine
New Brunswick, New Jersey
jnj.com
Large pharma
Pharmaceutical business of Johnson & Johnson, formerly Janssen, with medicines in oncology, immunology and neuroscience, including the CAR-T therapy Carvykti.
Poster
Wed Oct 28
1:30pm–3:30pm
From Guideline to Practice: Temperature Excursion Management
Manufacturing
Poster
Thu Oct 29
2:00pm–4:00pm
Assessment of shear stress induced saRNA–LNP instability for process development
Non viral delivery

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Johnson & Johnson Innovative Medicine

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction